SCHEMBL8284699

SCHEMBL8284699

Cc1ccc(O)c(Cn2c(N)nc3cc(C=O)ccc32)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.40
▸ POLB P06746 2/20 0.40
▸ HTT P42858 1/20 0.40
▸ KDM4E B2RXH2 5/20 0.38
▸ HPGD P15428 3/20 0.38
▸ USP2 O75604 1/20 0.38
▸ HSD17B10 Q99714 1/20 0.38
▸ TLR8 Q9NR97 1/20 0.37
▸ SOS1 Q07889 2/20 0.35
▸ HDAC1 Q13547 1/20 0.35
▸ HDAC8 Q9BY41 1/20 0.35
▸ BACE1 P56817 2/20 0.34
▸ NUDT1 P36639 1/20 0.34
▸ PTGS2 P35354 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ KMT2A Q03164 3/20 0.34
▸ TNF P01375 1/20 0.34
▸ CXCL8 P10145 1/20 0.34
▸ NOD2 Q9HC29 1/20 0.34
▸ NOD1 Q9Y239 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8284602 0.91 KDM4E (0.38) ALDH1A1POLBHTTKDM4EHPGD
SCHEMBL8284702 0.84 ALDH1A1 (0.46) ALDH1A1POLBHTTPTGDR2
SCHEMBL8284697 0.81 KDM4E (0.46) ALDH1A1POLBHTTKDM4EHPGD
SCHEMBL8284623 0.81 HTT (0.40) ALDH1A1POLBHTTKDM4ETLR8
SCHEMBL8284693 0.81 KDM4E (0.37) ALDH1A1KDM4EHPGDUSP2HSD17B10
SCHEMBL8249749 0.79 KDM4E (0.39) ALDH1A1KDM4EHPGDUSP2HSD17B10
SCHEMBL8286225 0.79 CSF1R (0.53) ALDH1A1POLBHTTHDAC1HDAC8
SCHEMBL8284670 0.79 KDM4E (0.37) ALDH1A1POLBHTTKDM4EHPGD
SCHEMBL8284696 0.78 SIRT2 (0.48) ALDH1A1KDM4EHPGDRAB9AKMT2A
SCHEMBL12226856 0.78 HDAC1 (0.41) ALDH1A1KDM4EHPGDUSP2HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8044073-B2 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication TIBOTEC PHARMACEUTICALS (IE) 2011-10-25 — — US disclosed
US-8044073-B2 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication TIBOTEC PHARMACEUTICALS (IE) 2011-10-25 — — US disclosed
EP-1697343-B1 AMINOBENZIMIDAZOLES AND BENZIMIDAZOLES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS REPLICATION TIBOTEC PHARM LTD (IE) 2009-07-01 — — EP disclosed
US-20070099924-A1 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication JANSSEN SCIENCES IRELAND UC (IE) 2007-05-03 — — US disclosed
US-20070099924-A1 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication JANSSEN SCIENCES IRELAND UC (IE) 2007-05-03 — — US disclosed
WO-2005058869-A1 AMINOBENZIMIDAZOLES AND BENZIMIDAZOLES AS INHIBITORS OF RESPIRATORY SYNCYTIAL VIRUS REPLICATION TIBOTEC PHARMACEUTICALS LTD. (IE) 2005-06-30 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099924-A1 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, H1-2, H1-4 ALDH1A1 1319/4885POLB 185/4885HTT 2862/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback